Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
01/02/1992 | EP0463466A2 Process for the preparation of high purity 5-aminosalicylic acid |
01/02/1992 | EP0463456A1 Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and their use |
01/02/1992 | EP0463407A2 Use of dihydropyridins in cardiotonic pharmaceutical compositions |
01/02/1992 | EP0463228A2 Injectable formulations containing the sodium salt of naproxen |
01/02/1992 | EP0463190A1 Minerals in bioavailable form |
01/02/1992 | EP0463173A1 Hair tonic and dressing composition |
01/02/1992 | EP0463162A1 PREPARATION OF 5,6,7-TRINOR-4,8-INTER-m-PHENYLENE PGI 2 DERIVATIVES |
01/02/1992 | EP0463139A1 2,13-disubstituted ergolins, their preparation and their use in drugs. |
01/02/1992 | EP0463126A1 Methods of enhancing wound healing and tissue repair |
01/02/1992 | EP0463123A1 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane derivatives, pharmaceutical compositions containing them and their use for the removal of toxic metal ions and radioactive isotopes from the living organism |
01/02/1992 | EP0462980A1 Platinum pharmaceutical agents |
01/02/1992 | EP0462964A1 Treatment of skin diseases and tumors |
01/02/1992 | EP0451299A4 Magnetocontrollable carrier with physiologically active substance and method for making said carrier |
01/02/1992 | EP0439513A4 Composition for inhibiting transmission of aids |
01/02/1992 | EP0425565A4 Silicon compounds in bone treatment |
01/02/1992 | EP0309541B1 Sulfonylcarboxamides |
01/02/1992 | EP0261148B1 Orally active nonaddicting analgesics |
01/02/1992 | EP0258435B1 Pyridazinone derivatives or salts thereof |
01/02/1992 | DE4019892A1 New xanthine derivs. are selective A1 adenosine antagonists - useful for treating CNS disorders (e.g. senile dementia) and heart and circulation disorders |
01/01/1992 | CN1057464A Pyrazolopyrimidinone antianginal agents |
01/01/1992 | CN1057463A 6-substituted purinyl piperazine derivatives |
01/01/1992 | CN1057462A Aminobenzodiazepine |
01/01/1992 | CN1057461A Benzopyran derivatives and heterocyclic analogs thereof as antiischemic agents |
01/01/1992 | CN1057458A Amino bicyclic compounds |
01/01/1992 | CN1057391A Use of magnesium-pyridoxal-5'-phosphate-glutaminate for prevention of diseases which result fromvascular lesions |
01/01/1992 | CN1057390A Pharmaceutical combination preparations containing cephalosporin and xanthine derivatives and their use |
01/01/1992 | CN1015264B Process for preparing orally active phosphonyl hydroxyacyl prolines |
01/01/1992 | CN1015263B Process for preparation of 3-propenyl cephalosporin solvates |
01/01/1992 | CN1015262B Process for preparation of beta-lactam antibiotics |
01/01/1992 | CN1015261B Process for preparation of carbapenem antibiotic |
01/01/1992 | CN1015259B Preparation of perhydrothiazepine derivative |
01/01/1992 | CN1015258B Process for preparation of cardiotonic aroylthiazolones |
01/01/1992 | CN1015256B Process for preparing substituting compounds of benzyl butenyl amido |
01/01/1992 | CN1015229B Process of preparation for blood vessel thrombotic agent (th glue) |
12/31/1991 | US5077428 Pharmacologically active derivatives of p-guanidinobenzoic acid |
12/31/1991 | US5077410 Hypotensive agents, antiedemic agents and diuretics |
12/31/1991 | US5077397 Sialic acid derivative with active ester groups |
12/31/1991 | US5077315 Treatment of HIV virus |
12/31/1991 | US5077313 Administering arginine, creatine, agmatine and salts thereof daily |
12/31/1991 | US5077312 Biologically active lipids binding membrane receptors |
12/31/1991 | US5077310 Granulation product of calcium ascorbate |
12/31/1991 | US5077308 Avermectin ketal derivatives useful as antiparasitic |
12/31/1991 | US5077307 Thienopyran derivatives, their use for treating hypertension and asthma |
12/31/1991 | US5077302 Urea derivatives |
12/31/1991 | US5077301 Side-effect inhibition |
12/31/1991 | US5077300 Anthelmintics |
12/31/1991 | US5077298 Administering neuroleptic agents |
12/31/1991 | US5077296 Method for treating equine navicular disease with pentoxifylline, and composition containing pentoxifylline for administrating to horses |
12/31/1991 | US5077295 Antipsychoic 4-(4-(3-benzisothiazolyl)-1-piperazinyl)buytl bridged bicycle imides |
12/31/1991 | US5077294 Products containing verapamil or gallopamil and prazosin |
12/31/1991 | US5077293 Antidepressants |
12/31/1991 | US5077292 (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same |
12/31/1991 | US5077289 Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine |
12/31/1991 | US5077288 Adrenergic, serotonin and histamine antagonist |
12/31/1991 | US5077287 3-thiazolylthio carbacephem antibacterial agents |
12/31/1991 | US5077286 Beta-lactam derivatives of the 4-acylcephem sulphone and 3-acylpenam sulphone-type |
12/31/1991 | US5077284 Viricides |
12/31/1991 | US5077281 Novel use of taurolin |
12/31/1991 | US5077277 Bactericides |
12/31/1991 | US5077211 Purification and administration of dna repair enzymes |
12/31/1991 | US5077202 Fractiomating whole lipids of marine chlorella, solvent extrac tion and column chromatography |
12/31/1991 | US5077055 Topical therapeutic system comprising 5-fluorouracil |
12/31/1991 | US5077054 Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug |
12/31/1991 | US5077052 Chitosan derivatives useful in compositions for coating feedstuff additives intended for ruminants |
12/31/1991 | US5077051 Sustained release of active agents from bioadhesive microcapsules |
12/31/1991 | US5077049 Placing solution of water coagulable thermoplastic polymer in water miscible nontoxic solvent into periodontal pocket, forming in situ solid porous implant; promotes cell growth |
12/31/1991 | US5077048 Water-soluble polymer, sodium and potassium salt of an organic salts of carboxylic acids, electrolyte balance; shelf life |
12/31/1991 | US5077047 Reacting fluidized bed of polymer with fine droplets of aqueou s peroxide; drying |
12/31/1991 | US5077036 Storage stability |
12/31/1991 | CA2045939A1 Process for the preparation of pyrimidine nucleosides |
12/31/1991 | CA1293735C Rooperol and its derivatives |
12/31/1991 | CA1293731C Derivatives of n-¬3-(2,4,6-trimethoxybenzoyl) propyl| piperidine, their preparation processes and their use in therapeutics |
12/31/1991 | CA1293728C Ascorbic acid derivatives, production and use thereof |
12/31/1991 | CA1293727C 9-deazaguanines |
12/31/1991 | CA1293724C Oxadiazolyl derivatives of imidazobenzodiazepines |
12/31/1991 | CA1293723C 1,2,4-oxadiazolyl derivatives of imidazo-: benzazepine, benzodiazepine, benzoxazepine and benzothiazepine |
12/31/1991 | CA1293722C2 N-6 substituted adenosine derivatives as cardiac vasodilators |
12/31/1991 | CA1293721C2 N-6 substituted adenosine derivatives as cardiac vasodilators |
12/31/1991 | CA1293719C Cephem compounds and processes for preparation thereof |
12/31/1991 | CA1293718C Method for production of cephalosporin compounds |
12/30/1991 | WO1992000302A1 Pure crystalline form of rifapentine |
12/30/1991 | WO1992000290A1 Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones |
12/30/1991 | WO1992000081A1 Vaccine compositions containing liposomes |
12/30/1991 | WO1992000078A1 Antiviral agents containing heteropolytungstate |
12/30/1991 | WO1992000074A2 Pyridopyrazine derivatives for treating substance abuse and addiction |
12/30/1991 | CA2086263A1 Antiviral agents containing heteropolytungstate |
12/30/1991 | CA2064796A1 Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones |
12/30/1991 | CA2045982A1 Use of the gm monosialoganglioside and of its internal ester derivative to prevent the insurgence in man of the |
12/30/1991 | CA2045925A1 2-(aminoalkyl)pyrrolealdehydes, process for their preparation and their use |
12/30/1991 | CA2045863A1 Process of making 2,5-diaryl tetrahydrofurans and analogs thereof useful as paf antagonists |
12/30/1991 | CA2045849A1 Oxazolopyridines derivatives, their preparation process and pharmaceutical compositions containing them |
12/30/1991 | CA2045847A1 Carbapenem antibacterial agents |
12/30/1991 | CA2044533A1 Substituted aminoalkylbiphenyl derivatives |
12/30/1991 | CA2043817A1 Process and intermediates for beta-lactams having aminothiazole (iminooxyacetic acid) acetic acid sidechains |
12/30/1991 | CA2020200A1 Use of sucralfate |
12/29/1991 | WO1992000279A1 Chemical compounds |
12/29/1991 | WO1992000068A1 Substituted histidines |
12/29/1991 | CA2084776A1 Substituted histidines |
12/29/1991 | CA2083710A1 Quinolinyl substituted phenyl/thioalkanoic acid substituted propionic acids |
12/29/1991 | CA2045868A1 2,4- and 2,5-substituted pyridine-n-oxides, processes for their preparation and their use |